SHL Telemedicine Ltd.
SHLT · NASDAQ
12/31/2024 | 6/30/2024 | 12/31/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | 0.13 | -0.03 | -0.01 |
| FCF Yield | -6.50% | -1.43% | 1.11% | -2.19% |
| EV / EBITDA | -2.89 | -443.84 | -15.33 | 152.32 |
| Quality | ||||
| ROIC | -39.06% | -4.27% | -4.55% | -3.58% |
| Gross Margin | 43.92% | 46.99% | 44.47% | 44.05% |
| Cash Conversion Ratio | 0.00 | 0.09 | -0.37 | 1.49 |
| Growth | ||||
| Revenue 3-Year CAGR | 11.31% | 11.47% | 8.39% | 8.83% |
| Free Cash Flow Growth | -132.73% | -211.69% | 128.05% | 32.62% |
| Safety | ||||
| Net Debt / EBITDA | -0.47 | -33.92 | -1.82 | 11.37 |
| Interest Coverage | -20.38 | 0.00 | 0.00 | -2.75 |
| Efficiency | ||||
| Inventory Turnover | 13.84 | 5.09 | 4.12 | 4.02 |
| Cash Conversion Cycle | 9.87 | 21.56 | 29.80 | 36.20 |